ADA (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Diabetes Care
Andreasen, N, Carpenter, W, Kane, J, Lasser, R, Marder, S, Weinberger, M (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry
Bleuler, M (1978). The Schizophrenic Disorders: Long-Term Patient and Family Studies. Yale University Press: New Haven, CT.
Bola, JR, Lehtinen, K, Cullberg, J, Ciompi, L (2009). Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first-episode psychosis: a review of the literature. Psychosis
Buchanan, R, Kreyenbuhl, J, Kelly, D, Noel, J, Boggs, D, Fischer, B, Himelhoch, S, Fang, B, Peterson, E, Aquino, P, Keller, W (2010). The 2009 Schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin
Chouinard, G, Jones, BD (1980). Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. American Journal of Psychiatry
Ciompi, L, Hoffmann, H (2004). Soteria Berne: an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic. World Psychiatry
Cohen, P, Cohen, J (1984). The clinician's illusions. Archive of General Psychiatry
Cornblatt, BA, Carrión, RE, Addington, J, Seidman, L, Walker, EF, Cannon, TD, Cadenhead, KS, McGlashan, TH, Perkins, DO, Tsuang, MT (2012). Risk factors for psychosis: impaired social and role functioning. Schizophrenia Bulletin
Cramer, JA, Rosenheck, R (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services
Davis, J, Chen, N, Glick, I (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry
Docherty, NM, St-Hilaire, A, Aakre, JM, Seghers, JP (2009). Life events and high-trait reactivity together predict psychotic symptom increases in schizophrenia. Schizophrenia Bulletin
Endicott, J, Spitzer, R (1978). A diagnostic interview. Archives of General Psychiatry
Fallon, P, Dursun, S, Deakin, B (2012). Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients. Therapeutic Advances in Psychopharmacology
Fenton, W, McGlashan, T (1987). Sustained remission in drug-free schizophrenic patients. American Journal of Psychiatry
Gardner, DM, Murphy, AL, O'Donnell, H, Centorrino, F, Baldessarini, RJ (2010). International consensus study of antipsychotic dosing. American Journal of Psychiatry
Gilbert, PL, Harris, MJ, McAdams, LA, Jeste, DV (1995). Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Archives of General Psychiatry
Goghari, V, Harrow, M, Grossman, L, Rosen, C (2013). A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders. Psychological Medicine
Harding, C, Brooks, G, Ashikiga, T, Strauss, J, Breier, A (1987). The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry
Harrow, M, Goldberg, J, Grossman, L, Meltzer, H (1990). Outcome in manic disorders. A naturalistic follow-up study. Archives of General Psychiatry
Harrow, M, Grossman, L, Jobe, T, Herbener, E (2005). Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophrenia Bulletin
Harrow, M, Jobe, TH (2007). Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multi-follow-up study. Journal of Nervous and Mental Disease
Harrow, M, Jobe, TH (2010). How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up. Schizophrenia Bulletin
Harrow, M, Jobe, TH (2013). Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?
Harrow, M, Jobe, TH, Faull, RN (2012). Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychological Medicine
Harrow, M, Jobe, TH, Herbener, ES, Goldberg, JF, Kaplan, KJ (2004). Thought disorder in schizophrenia: working memory and impaired context. Journal of Nervous and Mental Disease
Harrow, M, Quinlan, D (1985). Disordered Thinking and Schizophrenic Psychopathology. Gardner Press: New York, NY.
Harrow, M, Yonan, C, Sands, J, Marengo, J (1994). Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?
Healy, D (2002). The Creation of Psychopharmacology. Harvard University Press: Cambridge, MA.
Hegarty, J, Baldessarini, R, Tohen, M, Waternaux, C (1994). One hundred years of schizophrenia: a meta-analysis of the outcome literature. American Journal of Psychiatry
Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R, Magnotta, V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry
Holinger, D, Shenton, M, Wible, C, Donnino, R, Kikinis, R, Jolesz, F, McCarley, R (1999). Superior temporal gyrus volume abnormalities and thought disorder in left-handed schizophrenic men. American Journal of Psychiatry
Hollingshead, A, Redlich, F (1958). Social Class and Mental Illness. John Wiley & Sons: New York, NY.
Jääskeläinen, E, Juola, P, Hirvonen, N, McGrath, JJ, Saha, S, Isohanni, M, Veijola, J, Miettunen, J (2013). A systematic review and meta-analysis of recovery in schizophrenia. Schizophrenia Bulletin
Jablensky, A, Sartorius, N (2008). What did the WHO studies really find?
Jobe, TH, Harrow, M (2010). Schizophrenia course, long-term outcome, recovery, and prognosis. Current Directions in Psychological Science
Kendler, KS, Schaffner, KF (2011). The dopamine hypothesis of schizophrenia: an historical and philosophical analysis. Philosophy, Psychiatry, and Psychology
Kurita, M, Holloway, T, García-Bea, A, Kozlenkov, A, Friedman, AK, Moreno, JL, Takahashi, N (2012). HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nature Neuroscience
Lehman, AF, Lieberman, J, Dixon, L, McGlashan, T, Miller, A, Perkins, D, Kreyenbuhl, J (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry
Leucht, S, Tardy, M, Komossa, K, Heres, S, Kissling, W, Davis, JM (2012). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. Issue 5. Art. No. CD008016.
McGorry, P, Alvarez-Jimenez, M, Killackey, E (2013). Antipsychotic medication during the critical period following remission from first-episode psychosis: less is more. Journal of the American Medical Association. Psychiatry
McGurk, SR, Mueser, KT, Covell, NH, Cicerone, KD, Drake, RE, Silverstein, SM, Medialia, A, Myers, R, Bellack, AS, Bell, MD (2013). Mental health system funding of cognitive enhancement interventions for schizophrenia: summary and update of the New York Office of Mental Health expert panel and stakeholder meeting. Psychiatric Rehabilitation Journal
Moncrieff, J (2009
a). A critique of the dopamine hypothesis of schizophrenia and psychosis. Harvard Review of Psychiatry
Moncrieff, J (2009
b). The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment. Palgrave Macmillan: Basingstoke, UK.
Morrison, AP, Hutton, P, Shiers, D, Turkington, D (2012). Antipsychotics: is it time to introduce patient choice?
British Journal of Psychiatry
Mueser, KT, Deavers, F, Penn, DL, Cassisi, JE (2013). Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology
Murray, RM, Lappin, J, Di Forti, M (2008). Schizophrenia: from developmental deviance to dopamine dysregulation. European Neuropsychopharmacology
Osterberg, L, Blaschke, T (2005). Adherence to medication. New England Journal of Medicine
Sands, J, Harrow, M (1994). Psychotic unipolar depression at follow-up: factors related to psychosis in the affective disorders. American Journal of Psychiatry
Seeman, MV, Seeman, P (2014). Is schizophrenia a dopamine supersensitivity psychotic reaction?
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Seeman, P, Schwarz, J, Chen, JF, Szechtman, H, Perreault, M, McKnight, GS, Roder, JC, Quirion, R, Boksa, P, Srivastava, LK (2006). Psychosis pathways converge via D2high dopamine receptors. Synapse
Seikkula, J, Alakare, B, Aaltonen, J (2011). The comprehensive open-dialogue approach in Western Lapland: II. Long-term stability of acute psychosis outcomes in advanced community care. Psychosis
Silverstein, S, Bellack, A (2008). A scientific agenda for the concept of recovery as it applies to schizophrenia. Clinical Psychology Review
Stephens, J, Pascal, R, McHugh, P (1997). Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940. Journal of Nervous and Mental Disorders
Subotnik, K, Nuechterlein, K, Green, M, Horan, W, Nienow, T, Ventura, J, Nguyen, A (2006). Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophrenia Research
Tandon, R, Belmaker, R, Gattaz, WF (2008). World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophrenia Research
Tranter, R, Healy, D (1998). Neuroleptic discontinuation syndromes. Journal of Psychopharmacology
Vaillant, G (1978). A 10-year followup of remitting schizophrenics. Schizophrenia Bulletin
Whitaker, R (2011). Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. Broadway Books: New York, NY.
Wunderink, L, Nieboer, RM, Wiersma, D, Sytema, S, Nienhuis, FJ (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy long-term follow-up of a 2-year randomized clinical trial recovery in remitted first-episode psychosis. Journal of the American Medical Association. Psychiatry
Wunderink, L, Nienhuis, FJ, Sytema, S, Slooff, CJ, Knegtering, R, Wiersma, D (2007). Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. Journal of Clinical Psychiatry
Zigler, E, Glick, M (2001). The developmental approach to adult psychopathology. The Clinical Psychologist
Zipursky, RB, Reilly, TJ, Murray, RM (2013). The myth of schizophrenia as a progressive brain disease. Schizophrenia Bulletin